Cargando…

Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review

Chronic pain is a condition where patients continuously experience pain symptoms for at least 3 to 6 months. It is one of the leading causes of disabilities across the globe. Failure to adequately manage chronic pain often results in additional health concerns that may directly contribute to the wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishriky, John, Stupans, Ieva, Chan, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463420/
https://www.ncbi.nlm.nih.gov/pubmed/31015881
http://dx.doi.org/10.18549/PharmPract.2019.1.1410
_version_ 1783410754472378368
author Mishriky, John
Stupans, Ieva
Chan, Vincent
author_facet Mishriky, John
Stupans, Ieva
Chan, Vincent
author_sort Mishriky, John
collection PubMed
description Chronic pain is a condition where patients continuously experience pain symptoms for at least 3 to 6 months. It is one of the leading causes of disabilities across the globe. Failure to adequately manage chronic pain often results in additional health concerns that may directly contribute to the worsening symptoms of pain. Community pharmacists are an important healthcare resource that contributes to patient care, yet their roles in chronic pain management are often not fully utilised. This review aimed to investigate and explore pharmacist-driven chronic pain educational and medication management interventions in community pharmacies on an international level, and thereby identify if there are potential benefits in modelling and incorporating these interventions in the Australian community. We found a number of studies conducted in Europe and the United States investigated the benefits of pharmacist-driven educational and medication management interventions in the context of chronic pain management. Results demonstrated that there were improvements in the pain scores, depression/anxiety scales and physical functionality in patient groups receiving the pharmacist driven-interventions, thereby highlighting the clinical benefit of these interventions in chronic pain. In conclusion, pharmacists are trustworthy and responsible advocates for medication reviews and patient education. There are currently very limited formal nationally recognised pharmacist-driven intervention programs dedicated to chronic pain management in Australian community pharmacies. International studies have shown that pharmacist-driven chronic pain interventions undertaken in community pharmacies are of benefit with regards to alleviating pain symptoms and adverse events. Furthermore, it is also clear that research around the application of pharmacist-led chronic pain interventions in Australia is lacking. Modelling interventions that have been conducted overseas may be worth exploring in Australia. The implementation of similar intervention programs for Australian pharmacists in community pharmacies may provide enhanced clinical outcomes for patients suffering from chronic pain. The recently implemented Chronic Pain MedsCheck Trial may provide some answers.
format Online
Article
Text
id pubmed-6463420
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-64634202019-04-23 Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review Mishriky, John Stupans, Ieva Chan, Vincent Pharm Pract (Granada) Review Chronic pain is a condition where patients continuously experience pain symptoms for at least 3 to 6 months. It is one of the leading causes of disabilities across the globe. Failure to adequately manage chronic pain often results in additional health concerns that may directly contribute to the worsening symptoms of pain. Community pharmacists are an important healthcare resource that contributes to patient care, yet their roles in chronic pain management are often not fully utilised. This review aimed to investigate and explore pharmacist-driven chronic pain educational and medication management interventions in community pharmacies on an international level, and thereby identify if there are potential benefits in modelling and incorporating these interventions in the Australian community. We found a number of studies conducted in Europe and the United States investigated the benefits of pharmacist-driven educational and medication management interventions in the context of chronic pain management. Results demonstrated that there were improvements in the pain scores, depression/anxiety scales and physical functionality in patient groups receiving the pharmacist driven-interventions, thereby highlighting the clinical benefit of these interventions in chronic pain. In conclusion, pharmacists are trustworthy and responsible advocates for medication reviews and patient education. There are currently very limited formal nationally recognised pharmacist-driven intervention programs dedicated to chronic pain management in Australian community pharmacies. International studies have shown that pharmacist-driven chronic pain interventions undertaken in community pharmacies are of benefit with regards to alleviating pain symptoms and adverse events. Furthermore, it is also clear that research around the application of pharmacist-led chronic pain interventions in Australia is lacking. Modelling interventions that have been conducted overseas may be worth exploring in Australia. The implementation of similar intervention programs for Australian pharmacists in community pharmacies may provide enhanced clinical outcomes for patients suffering from chronic pain. The recently implemented Chronic Pain MedsCheck Trial may provide some answers. Centro de Investigaciones y Publicaciones Farmaceuticas 2019 2019-02-18 /pmc/articles/PMC6463420/ /pubmed/31015881 http://dx.doi.org/10.18549/PharmPract.2019.1.1410 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Mishriky, John
Stupans, Ieva
Chan, Vincent
Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review
title Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review
title_full Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review
title_fullStr Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review
title_full_unstemmed Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review
title_short Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review
title_sort expanding the role of australian pharmacists in community pharmacies in chronic pain management - a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463420/
https://www.ncbi.nlm.nih.gov/pubmed/31015881
http://dx.doi.org/10.18549/PharmPract.2019.1.1410
work_keys_str_mv AT mishrikyjohn expandingtheroleofaustralianpharmacistsincommunitypharmaciesinchronicpainmanagementanarrativereview
AT stupansieva expandingtheroleofaustralianpharmacistsincommunitypharmaciesinchronicpainmanagementanarrativereview
AT chanvincent expandingtheroleofaustralianpharmacistsincommunitypharmaciesinchronicpainmanagementanarrativereview